We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

STX Shield Therapeutics Plc

0.15 (5.36%)
Last Updated: 10:17:20
Delayed by 15 minutes

Shield Therapeutics Financial Summary

The current STX market cap is 22.88M. The company's latest EPS is GBP -0.0522 and P/E is -0.57.

Year End 31 December 2022 20182019202020212022
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Revenue 11.88M719k10.39M1.52M4.47M
Operating Income -5.16M-9.04M-2.15M-20.29M-40.41M
Net Income -1.79M-8.8M-2.63M-19.68M-40.44M
Year End 31 December 2022 20182019202020212022
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Assets 43.53M36.32M32.53M44.41M22.07M
Total Liabilities 3.1M4.17M2.25M3.72M16.65M
Total Equity 40.43M32.15M30.28M40.69M5.43M

Cash Flow

Year End 31 December 2022 20182019202020212022
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Operating 151k-4.07M-1.4M-18.26M-17.31M
Investing -3.3M-1.37M-20k-2.05M-1.87M
Financing -379k-203k-47k27.71M7.01M
Market Cap 22.88M
Price to Earnings Ratio -0.57
Price to Sales Ratio 5.09
Price to Cash Ratio 8.19
Price to Book Ratio 4.22
Dividend Yield -

Share Statistics

Shares Outstanding 775.43M
Average Volume (1 week) 33.87M
Average Volume (1 Month) 9.75M
52 Week Change -61.18%
52 Week High 12.75
52 Week Low 2.525
Spread (Intraday) 0.1 (3.33%)

Company Info

Company Name Shield Therapeutics Plc
Address northern design centre
newcastle upon tyne NE8 3DF
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |